anthrax vaccine (DynPort/AVANT)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanthrax vaccine (DynPort/AVANT)
Drug Alias Nameinjectable anthrax vaccine (DynPort/AVANT)
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionAnthrax protective antigen modulators
TargetsAnthrax protective antigen
Therapy Area/IndicationsAnthrax
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCelldex Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelldex Therapeutics IncDynport Vaccine Company Llc
Active IndicationsN/A
Inactive IndicationsAnthrax

Other Information

ATC CodeN/A
Related LinksN/A